Home » Newsletters » BioWorld

BioWorld

April 23, 1992

View Archived Issues

STABLE DAY FOR STOCKS

AGOURON TREATMENT MATCHES PLACEBO

PATENT COVERS HEPATITIS C TEST

ORGANOGENESIS PATENT COVERS ITS COLLAGEN

ANOTHER WOULD-BE IPO BACKS AWAY

REVIEWS SAY E5, CENTOXIN STILL UNPROVEN

ZYNAXIS COLLABORATION WITH LILLY

CALGENE AWARDED ANTISENSE PATENT

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...